Guidelines for the risk assessment of new synthetic drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Luxembourg
Office for Official Publ. of the European Communities
1999
|
| Schlagworte: | |
| Beschreibung: | 33 S. |
| ISBN: | 9291680613 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV012745200 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 990906s1999 lu |||| 00||| eng d | ||
| 020 | |a 9291680613 |9 92-9168-061-3 | ||
| 035 | |a (OCoLC)247250988 | ||
| 035 | |a (DE-599)BVBBV012745200 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a lu |c XA-LU | ||
| 049 | |a DE-12 |a DE-355 |a DE-521 | ||
| 050 | 0 | |a RM301.9.E94 1999 | |
| 082 | 0 | |a 615/.31 21 | |
| 084 | |a MS 6410 |0 (DE-625)123754: |2 rvk | ||
| 084 | |a PS 3884 |0 (DE-625)139813: |2 rvk | ||
| 245 | 1 | 0 | |a Guidelines for the risk assessment of new synthetic drugs |c E.M.C.D.D.A. |
| 264 | 1 | |a Luxembourg |b Office for Official Publ. of the European Communities |c 1999 | |
| 300 | |a 33 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 610 | 2 | 7 | |a Europäische Union |0 (DE-588)5098525-5 |2 gnd |9 rswk-swf |
| 650 | 7 | |a Droghe - consumo - aspetti giuridici |2 sbt | |
| 650 | 7 | |a Droghe - effetti fisiologici |2 sbt | |
| 650 | 7 | |a Ecstasy - consumo - Europa |2 sbt | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Drug monitoring -- Government policy -- European Union countries | |
| 650 | 4 | |a Synthetic drugs -- European Union countries | |
| 650 | 0 | 7 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Synthetische Droge |0 (DE-588)4217170-2 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Europäische Union. Mitgliedsstaaten | |
| 689 | 0 | 0 | |a Europäische Union |0 (DE-588)5098525-5 |D b |
| 689 | 0 | 1 | |a Synthetische Droge |0 (DE-588)4217170-2 |D s |
| 689 | 0 | 2 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-008667473 | |
Datensatz im Suchindex
| _version_ | 1820127996761079808 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV012745200 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.9.E94 1999 |
| callnumber-search | RM301.9.E94 1999 |
| callnumber-sort | RM 3301.9 E94 41999 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | MS 6410 PS 3884 |
| ctrlnum | (OCoLC)247250988 (DE-599)BVBBV012745200 |
| dewey-full | 615/.3121 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.31 21 |
| dewey-search | 615/.31 21 |
| dewey-sort | 3615 231 221 |
| dewey-tens | 610 - Medicine and health |
| discipline | Rechtswissenschaft Soziologie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV012745200</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">990906s1999 lu |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9291680613</subfield><subfield code="9">92-9168-061-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)247250988</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012745200</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">lu</subfield><subfield code="c">XA-LU</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-521</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.9.E94 1999</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.31 21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 6410</subfield><subfield code="0">(DE-625)123754:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PS 3884</subfield><subfield code="0">(DE-625)139813:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Guidelines for the risk assessment of new synthetic drugs</subfield><subfield code="c">E.M.C.D.D.A.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Luxembourg</subfield><subfield code="b">Office for Official Publ. of the European Communities</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">33 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Droghe - consumo - aspetti giuridici</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Droghe - effetti fisiologici</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ecstasy - consumo - Europa</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug monitoring -- Government policy -- European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Synthetic drugs -- European Union countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Synthetische Droge</subfield><subfield code="0">(DE-588)4217170-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europäische Union. Mitgliedsstaaten</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Synthetische Droge</subfield><subfield code="0">(DE-588)4217170-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008667473</subfield></datafield></record></collection> |
| geographic | Europäische Union. Mitgliedsstaaten |
| geographic_facet | Europäische Union. Mitgliedsstaaten |
| id | DE-604.BV012745200 |
| illustrated | Not Illustrated |
| indexdate | 2025-01-02T09:15:21Z |
| institution | BVB |
| isbn | 9291680613 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008667473 |
| oclc_num | 247250988 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-521 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-521 |
| physical | 33 S. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Office for Official Publ. of the European Communities |
| record_format | marc |
| spelling | Guidelines for the risk assessment of new synthetic drugs E.M.C.D.D.A. Luxembourg Office for Official Publ. of the European Communities 1999 33 S. txt rdacontent n rdamedia nc rdacarrier Europäische Union (DE-588)5098525-5 gnd rswk-swf Droghe - consumo - aspetti giuridici sbt Droghe - effetti fisiologici sbt Ecstasy - consumo - Europa sbt Politik Drug monitoring -- Government policy -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd rswk-swf Synthetische Droge (DE-588)4217170-2 gnd rswk-swf Europäische Union. Mitgliedsstaaten Europäische Union (DE-588)5098525-5 b Synthetische Droge (DE-588)4217170-2 s Gesundheitsgefährdung (DE-588)4071808-6 s DE-604 |
| spellingShingle | Guidelines for the risk assessment of new synthetic drugs Europäische Union (DE-588)5098525-5 gnd Droghe - consumo - aspetti giuridici sbt Droghe - effetti fisiologici sbt Ecstasy - consumo - Europa sbt Politik Drug monitoring -- Government policy -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd Synthetische Droge (DE-588)4217170-2 gnd |
| subject_GND | (DE-588)5098525-5 (DE-588)4071808-6 (DE-588)4217170-2 |
| title | Guidelines for the risk assessment of new synthetic drugs |
| title_auth | Guidelines for the risk assessment of new synthetic drugs |
| title_exact_search | Guidelines for the risk assessment of new synthetic drugs |
| title_full | Guidelines for the risk assessment of new synthetic drugs E.M.C.D.D.A. |
| title_fullStr | Guidelines for the risk assessment of new synthetic drugs E.M.C.D.D.A. |
| title_full_unstemmed | Guidelines for the risk assessment of new synthetic drugs E.M.C.D.D.A. |
| title_short | Guidelines for the risk assessment of new synthetic drugs |
| title_sort | guidelines for the risk assessment of new synthetic drugs |
| topic | Europäische Union (DE-588)5098525-5 gnd Droghe - consumo - aspetti giuridici sbt Droghe - effetti fisiologici sbt Ecstasy - consumo - Europa sbt Politik Drug monitoring -- Government policy -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd Synthetische Droge (DE-588)4217170-2 gnd |
| topic_facet | Europäische Union Droghe - consumo - aspetti giuridici Droghe - effetti fisiologici Ecstasy - consumo - Europa Politik Drug monitoring -- Government policy -- European Union countries Synthetic drugs -- European Union countries Gesundheitsgefährdung Synthetische Droge Europäische Union. Mitgliedsstaaten |